{
    "id": 16231,
    "fullName": "PRCC - TFE3",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PRCC-TFE3 results from the fusion of PRCC and TFE3 (PMID: 11313942). PRCC-TFE3 results in transcriptional activation of the Tfe3 target gene, SERPINE1 (referred to as PAI-1) (PMID: 11313942).",
            "references": [
                {
                    "id": 4208,
                    "pubMedId": 11313942,
                    "title": "PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11313942"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5546,
        "geneSymbol": "PRCC",
        "terms": [
            "PRCC",
            "RCCP1",
            "TPRC"
        ]
    },
    "variant": "PRCC - TFE3",
    "createDate": "01/06/2016",
    "updateDate": "01/06/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 7030,
                "geneSymbol": "TFE3",
                "terms": [
                    "TFE3",
                    "bHLHe33",
                    "RCCP2",
                    "RCCX1",
                    "TFEA"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 15801,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BEZ235 inhibited proliferation of a renal cell carcinoma cell line harboring PRCC-TFE3 in culture, with increased anti-proliferative effect compared to PI3K or mTOR inhibition alone (PMID: 30061365).",
            "molecularProfile": {
                "id": 16503,
                "profileName": "PRCC - TFE3"
            },
            "therapy": {
                "id": 672,
                "therapyName": "BEZ235",
                "synonyms": null
            },
            "indication": {
                "id": 4450,
                "name": "renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 13814,
                    "pubMedId": 30061365,
                    "title": "Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30061365"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 16503,
            "profileName": "PRCC - TFE3",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}